Literature DB >> 29845932

Managing with Learning Disability and Diabetes: OK-Diabetes - a case-finding study and feasibility randomised controlled trial.

Allan House1, Louise Bryant1, Amy M Russell1, Alexandra Wright-Hughes2, Liz Graham2, Rebecca Walwyn2, Judy M Wright1, Claire Hulme1, John L O'Dwyer1, Gary Latchford1, Shaista Meer1, Jacqueline C Birtwistle1, Alison Stansfield3, Ramzi Ajjan4, Amanda Farrin2.   

Abstract

BACKGROUND: Obesity and type 2 diabetes are common in adults with a learning disability. It is not known if the principles of self-management can be applied in this population.
OBJECTIVES: To develop and evaluate a case-finding method and undertake an observational study of adults with a learning disability and type 2 diabetes, to develop a standardised supported self-management (SSM) intervention and measure of adherence and to undertake a feasibility randomised controlled trial (RCT) of SSM versus treatment as usual (TAU).
DESIGN: Observational study and an individually randomised feasibility RCT.
SETTING: Three cities in West Yorkshire, UK. PARTICIPANTS: In the observational study: adults aged > 18 years with a mild or moderate learning disability, who have type 2 diabetes that is not being treated with insulin and who are living in the community. Participants had mental capacity to consent to research and to the intervention. In the RCT participants had glycated haemoglobin (HbA1c) levels of > 6.5% (48 mmol/mol), a body mass index (BMI) of > 25 kg/m2 or self-reported physical activity below national guideline levels.
INTERVENTIONS: Standardised SSM. TAU supported by an easy-read booklet. MAIN OUTCOME MEASURES: (1) The number of eligible participants identified and sources of referral; (2) current living and support arrangements; (3) current health state, including level of HbA1c, BMI and waist circumference, blood pressure and lipids; (4) mood, preferences for change; (5) recruitment and retention in RCT; (6) implementation and adherence to the intervention; (7) completeness of data collection and values for candidate primary outcomes; and (8) qualitative data on participant experience of the research process and intervention.
RESULTS: In the observational study we identified 147 eligible consenting participants. The mean age was 54.4 years. In total, 130 out of 147 (88%) named a key supporter, with 113 supporters (77%) being involved in diabetes management. The mean HbA1c level was 54.5 mmol/mol [standard deviation (SD) 14.8 mmol/mol; 7.1%, SD 1.4%]. The BMI of 65% of participants was > 30 kg/m2 and of 21% was > 40 kg/m2. Many participants reported low mood, dissatisfaction with lifestyle and diabetes management and an interest in change. Non-response rates were high (45/147, 31%) for medical data requested from the primary care team. In the RCT, 82 participants were randomised. The mean baseline HbA1c level was 56 mmol/mol (SD 16.5 mmol/mol; 7.3%, SD 1.5%) and the mean BMI was 34 kg/m2 (SD 7.6 kg/m2). All SSM sessions were completed by 35 out of 41 participants. The adherence measure was obtained in 37 out of 41 participants. The follow-up HbA1c level and BMI was obtained for 75 out of 82 (91%) and 77 out of 82 (94%) participants, respectively. Most participants reported a positive experience of the intervention. A low response rate and difficulty understanding the EuroQol-5 Dimensions were challenges in obtaining data for an economic analysis. LIMITATIONS: We recruited from only 60% of eligible general practices, and 90% of participants were on a general practice learning disability register, which meant that we did not recruit many participants from the wider population with milder learning disability.
CONCLUSIONS: A definitive RCT is feasible and would need to recruit 194 participants per arm. The main barrier is the resource-intensive nature of recruitment. Future research is needed into the effectiveness of obesity treatments in this population, particularly estimating the longer-term outcomes that are important for health benefit. Research is also needed into improving ways of assessing quality of life in adults with a learning disability. TRIAL REGISTRATION: Current Controlled Trials ISRCTN41897033. FUNDING: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 22, No. 26. See the NIHR Journals Library website for further project information.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29845932      PMCID: PMC5994644          DOI: 10.3310/hta22260

Source DB:  PubMed          Journal:  Health Technol Assess        ISSN: 1366-5278            Impact factor:   4.014


  4 in total

1.  Identifying people with a learning disability: an advanced search for general practice.

Authors:  Amy M Russell; Louise Bryant; Allan House
Journal:  Br J Gen Pract       Date:  2017-10-23       Impact factor: 5.386

2.  Diabetes management intervention studies: lessons learned from two studies.

Authors:  Bettina Petersen; Iris Vesper; Bernhild Pachwald; Nicole Dagenbach; Sina Buck; Delia Waldenmaier; Lutz Heinemann
Journal:  Trials       Date:  2021-01-18       Impact factor: 2.279

Review 3.  Health Promotion and Wellness Initiatives Targeting Chronic Disease Prevention and Management for Adults with Intellectual and Developmental Disabilities: Recent Advancements in Type 2 Diabetes.

Authors:  L Taggart; M Truesdale; A Dunkley; A House; A M Russell
Journal:  Curr Dev Disord Rep       Date:  2018-06-23

4.  The feasibility of using the EQ-5D-3L with adults with mild to moderate learning disabilities within a randomized control trial: a qualitative evaluation.

Authors:  A M Russell; J L O'Dwyer; L D Bryant; A O House; J C Birtwistle; S Meer; A Wright-Hughes; R E A Walwyn; E Graham; A J Farrin; C T Hulme
Journal:  Pilot Feasibility Stud       Date:  2018-10-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.